Arama

EISSN 1305-3612

5-YEAR IMPACT FACTOR: 2:093 IMPACT FACTOR: 1.871

Diagnostic and Interventional Radiology

PDF

IMAGES FROM THE LAST ISSUE

HIGHLY CITED ARTICLES

Dual-energy CT revisited with multidetector CT: review of principles and clinical applications

By: Karcaaltincaba, Musturay; Aktas, Aykut

CT measurement of trunk muscle areas in patients with chronic low back pain

By: Kamaz, Muezeyyen; Kiresi, Demet; Oguz, Hasan; et al.

MRI of the lung: state of the art

By: Wielpuetz, Mark; Kauczor, Hans-Ulrich

Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses

By: Demir, Oezguen Ilhan; Obuz, Funda; Sagol, Oezguel; et al.

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

By: Turkbey, Baris; Thomasson, David; Pang, Yuxi; et al.

Doctors' and intern doctors' knowledge about patients' ionizing radiation exposure doses during common radiological examinations

By: Arslanoglu, Atilla; Bilgin, Sibel; Kubali, Zehra; et al.

Differentiation of cytotoxic and vasogenic edema in a patient with reversible posterior leukoencephalopathy syndrome using diffusion-weighted MRI

By: Doelken, Marc; Lanz, Stefan; Rennert, Janine; et al.

Diagnosis and management of hemoptysis

By: Larici, Anna Rita; Franchi, Paola; Occhipinti, Mariaelena; et al.

Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging?

By: Iwazawa, Jin; Mitani, Takashi; Sassa, Seitaro; et al.

Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 16 results

Ranking

Release Date Sort Sort Article Type

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

Barış Türkbey, David Thomasson, Yuxi Pang, Marcelino Bernardo, Peter L. Choyke

(Diagn Interv Radiol 2010; 16: 186-192) DOI: 10.4261/1305-3825.DIR.2537-08.1

Abstract Full Text (PDF) Related Articles

MRI of localized prostate cancer: coming of age in the PSA era

Barış Türkbey, Marcelino Bernardo, Maria J. Merino, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke

(Diagn Interv Radiol 2012; 18: 34-45) DOI: 10.4261/1305-3825.DIR.4478-11.1

Abstract Full Text (PDF) Related Articles

Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging

Barış Türkbey, Ömer Aras, Nevzat Karabulut, Ahmet Tuncay Turgut, Erhan Akpınar, Sedat Alibek, Yuxi Pang, Şükrü Mehmet Ertürk, Riham H. El Khouli, David A. Bluemke, Peter L. Choyke

(Diagn Interv Radiol 2012; 18: 46-59) DOI: 10.4261/1305-3825.DIR.4708-11.2

Abstract Full Text (PDF) Related Articles

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

MRI of localized prostate cancer: coming of age in the PSA era

Diffusion-weighted MRI for detecting and monitoring cancer: a review of current applications in body imaging

Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia

Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session

Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up

Image-guided focal therapy for prostate cancer

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

PIRADS 2.0: what is new?

Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer

The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment

Semi-automatic 3D-volumetry of liver metastases from neuroendocrine tumors to improve combination therapy with 177Lu-DOTATOC and 90Y-DOTATOC

Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy

Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience

Artificial intelligence at the intersection of pathology and radiology in prostate cancer

Magnetic resonance imaging-guided focal laser ablation of prostate cancer: a prospective single arm, single center trial with 3 years of follow-up